InvestorsHub Logo
Followers 66
Posts 7528
Boards Moderated 0
Alias Born 03/06/2016

Re: georgebailey post# 671466

Saturday, 02/10/2024 9:16:15 PM

Saturday, February 10, 2024 9:16:15 PM

Post# of 703817
Can you or anyone help me understand when they mention OS at 22.3 months as significant potential when we know of cases where OS is over 10 years?....
Where is 22.3 often mention when the results are better than 22.3?

Thanks.


"Patients receiving the combined therapy exhibited a prolonged median OS (22.3 months after surgery in patients with newly diagnosed GBM and 13.2 months after relapse in patients with recurrent GBM); therefore, DCVax-L has substantial potential in the treatment in GBM.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News